User:Melrosejackson/sandbox

Possible Changes to article Duchenne muscular dystrophy
1. Summary 2. Medicine for treatment 3. Clincher

Reading List

 * 1) https://en.wikipedia.org/wiki/Duchenne_muscular_dystrophy
 * 2) | Ataluren for Duchenne muscular dystrophy
 * 3) http://www.mayoclinic.org/diseases-conditions/muscular-dystrophy/basics/symptoms/con-20021240
 * 4) http://www.businesswire.com/news/home/20150507005236/en/Pharmaceutical-Companies-Support-Cure-Duchenne-Cares-Provide
 * 5) http://www.nlm.nih.gov/medlineplus/ency/article/000705.htm
 * 6) https://www.mda.org/disease/duchenne-muscular-dystrophy
 * 7) PARKER, JN; PARKER, PM; ICON GROUP INTERNATIONAL, I. The 2002 Official Patient's Sourcebook on Muscular Dystrophy. San Diego, Calif : Icon Health Publications, 2002. ISBN: 9780597832109.
 * 8) WINDER, SJ. Molecular Mechanisms of Muscular Dystrophies. Georgetown, Tex : Landes Bioscience, 2006. (Molecular Biology Intelligence Unit). ISBN: 9781587062643

Original
Duchenne muscular dystrophy (DMD) is a recessive X-linked form of muscular dystrophy, affecting around 1 in 3,600 males, which results in muscle degeneration and premature death.[1] The disorder is caused by a mutation in the dystrophin gene, located on the human X chromosome, which codes for the protein dystrophin. Dystrophin is an important structural component within muscle tissue that provides structural stability to the dystroglycan complex (DGC) of the cell membrane. While both sexes can carry the mutation, females rarely exhibit signs of the disease.

Rewrite and review version April 29, 2015:
Duchenne muscular dystrophy (DMD) is a recessive X-link form of muscular dystrophy,affecting about 1 in 3,600 males, which results in muscle deterioration and premature death.[1] The disorder is caused by a mutation in the dystrophin gene, located on the human X chromosome, which codes for the protein dystrophin. Dystrophin is an important structural component within the muscle tissue that provides structural stability to the dystroglycan complex(DGC) of the cell membrane. While both sexes carry the mutation, females rarely exhibit signs of the disease. — Preceding unsigned comment added by Melrosejackson (talk • contribs) 23:36, 29 April 2015

original contribution
Muscular Dystrophy Association provides excellent research on available treatments and therapies for patients living with Duchenne muscular dystrophy (DMD). | Atalurenis a drug recommended by the European Medicine Agency (EMA)for treatment of Duchenne duscular dystrophy in patients age five years and older who are able to walk. This is an orphandesignated drug for treatment in this disease. "A DMD diagnosis does not mean an end to your hopes and dreams. Changes, challenges and adaptations lay ahead, but also opportunity, fulfillment, joy and hope for a future free of Duchenne muscular dystrophy".  (UTC)